DBV Technologies S.A. (DBVT) vs OmniAb, Inc. (OABI)
DBV Technologies S.A. and OmniAb, Inc. are both Biotechnology companies. DBV Technologies S.A. and OmniAb, Inc. are of similar size ($734.7M and $697.9M). OmniAb, Inc. grew revenue faster over the last twelve months: 67.0% against 27.1%. OmniAb, Inc. has the higher net margin (−115.1% vs −3,564.6%) and the lower return on invested capital (−14.5% vs 0.00%). Across the 16 metrics below, OmniAb, Inc. leads on 13 and DBV Technologies S.A. on 3.
Valuation
Profitability
| Metric | DBVT | OABI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 98.28% | 65.16% |
| Operating margin | (3,601.22%) | (125.78%) | 0.00% |
| Net margin | (3,564.57%) | (115.12%) | 0.00% |
| Free cash flow margin | (3,456.50%) | (47.17%) | 0.00% |
| Return on equity | (142.63%) | (16.95%) | (57.72%) |
| Return on assets | (95.98%) | (15.11%) | (49.22%) |
| Return on invested capital | 0.00% | (14.52%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack